Hydroxocobalamin-Acetate shortage — live status in 4 countries | Mederti
Hydroxocobalamin-Acetate shortage status
Current shortage summary
7 active shortage notices · 4 countries. Hydroxocobalamin-Acetate has 7 active shortage notices across 4 countries (United States, Australia, Belgium, Germany), plus 1 anticipated. Information last verified by Mederti on 11 Nov 2026, based on notices published by TGA, BfArM, FDA, FAMHP.
Generic name (INN)
Hydroxocobalamin-Acetate
Brand names
COBAL-B12 INJECTION hydroxocobalamin acetate
Class
Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
European Union: resolved 10 May 2026 (began 19 Dec 2024)
What the statuses mean
Active shortage:
A national regulator currently lists the notice as an ongoing shortage or supply disruption for at least one product (strength, form or pack) of the medicine.
Anticipated shortage:
The regulator or manufacturer has announced a shortage that has not started yet, or is expected. Not a Mederti prediction.
Resolved:
The regulator has closed the notice or removed it from its shortage list. This does not confirm that every product is back in stock.
No shortage notice on record:
Mederti receives data from this country's regulator but holds no notice linked to this medicine record. Some regulators file notices under a salt or local-language name (for example "amoxicillin trihydrate" or "amoxicillinum") that may be held as a separate record, so check the country's register. Never confirmation of supply at any pharmacy or wholesaler.
Data unavailable:
Mederti has no shortage data source for this country, so its status is unknown.
Frequently asked questions
Is Hydroxocobalamin-Acetate currently in shortage?
Yes. As of the latest regulator updates, Hydroxocobalamin-Acetate has 7 active shortage notices across 4 countries (United States, Australia, Belgium, Germany). Status is refreshed daily from official regulatory sources.
Why is Hydroxocobalamin-Acetate in shortage?
Regulators attribute the current Hydroxocobalamin-Acetate shortages to causes not stated by the regulator, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Hydroxocobalamin-Acetate shortage be resolved?
Regulator-estimated resolution dates currently range from 1 May 2025 to 31 Dec 2030, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Hydroxocobalamin-Acetate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Hydroxocobalamin-Acetate status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Mederti is an independent information service that aggregates notices published by official national medicines regulators, checked daily. It is not a regulator and is not affiliated with or endorsed by any regulator. A regulator's shortage status does not confirm or rule out commercial stock at any pharmacy or wholesaler. This page is not clinical advice; check the official notice and consult a pharmacist or prescriber before changing treatment.